(Q60637106)

2

0 references

Kym Baum

3

0 references

Dana M. Davis

4

0 references

Donald Diforio

5

0 references

Andrea Bergman

Development and Psychopathology

6

0 references

publication date

September 1996

0 references

published in

0 references

volume

8

0 references

issue

04

0 references

page(s)

647

0 references

cites work

Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

The Finnish adoptive family study of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Increased Cortisol Levels in Aging and Alzheimer's Disease in Postmortem Cerebrospinal Fluid

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Circadian and Sleep-Related Endocrine Rhythms in Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Prediction of adult-onset schizophrenia from childhood home movies of the patients.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Isometric force control in schizophrenic patients with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Neurotoxicity of glucocorticoids in the primate brain

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Neuroendocrine responses to challenge with dl-fenfluramine and aggression in disruptive behavior disorders of children and adolescents

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Effects of parental absence and institutionalization on the development of clinical symptoms in high‐risk children

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Effect of gestational age, postnatal age, and illness on plasma cortisol concentrations in premature infants.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Neuroendocrine and side effect profile of pramipexole, a new dopamine receptor agonist, in humans

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Adrenal cortical response to stress at Three Mile Island.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Institutional rearing and diagnostic outcome in children of schizophrenic mothers. A prospective high-risk study.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

High-dose naloxone modifies cardiovascular and neuroendocrine function in ambulant subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Abnormal involuntary movements and chronic schizophrenic disorders.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

The relationship between hormonal mediators and systemic hypermetabolism after severe head injury

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Schizotypal and paranoid personality disorder in the relatives of patients with schizophrenia and affective disorders: a review

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Treatment of negative symptoms

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Neuroendocrine responses in chronic schizophrenia. Evidence for serotonergic dysfunction.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Further investigation of the predictors of outcome following first schizophrenic episodes

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Prenatal stress in rats facilitates amphetamine-induced sensitization and induces long-lasting changes in dopamine receptors in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect. A review and replication analysis of pandysmaturation in the Jerusalem Infant Development Study

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Stress, feedback and facilitation in the hypothalamo-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Effect of age and sex on cortisol secretion in depressives and normals

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Patterns of Childhood Social Development in Adult Schizophrenics

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Neuromotor precursors of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Fine force instability: a quantitative measure of neuroleptic-induced dyskinesia in the hand

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Central administration of corticotropin releasing factor induces long-term sensitization to D-amphetamine

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Sub-syndromes of tardive dyskinesia and some clinical correlates

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Sex differences in psychoneuroendocrine reactions to examination stress.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

The effect of diagnosis and age on the DST: a metaanalytic approach

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

DST and schizophrenic symptomatology

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Dexamethasone suppression test, schizophrenia and movement disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Behavioral antecedents of adult schizophrenia. A review

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Clozapine attenuates meta-chlorophenylpiperazine (mCPP)-induced plasma cortisol increases in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Perinatal complications and reduced size of brain limbic structures in familial schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Specificity of the salivary cortisol dexamethasone suppression test across psychiatric diagnoses.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Cellular mechanisms underlying the development and expression of individual differences in the hypothalamic-pituitary-adrenal stress response

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Prolactin and growth hormone responses to growth hormone-releasing hormone in acute schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

The dexamethasone suppression test and negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Childhood precursors of schizophrenia: facial expressions of emotion.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Deficit and nondeficit forms of schizophrenia: the concept

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Effects of the acute administration of caffeine in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Childhood Neuromotor Soft Signs, Behavior Problems, and Adult Psychopathology

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Abnormal Movements and Prognosis in Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Salivary cortisol hypersecretion in juvenile depression

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

A chart review of schizotypal personality disorders in children

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Psychotic and nonpsychotic depressions: I. Comparison of plasma catecholamines and cortisol measures

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Blunted acth response to hypoglycemic stress in depressed patients but not in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Stressful life events and schizophrenia. I: A review of the research

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia?

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Three syndrome concept of schizophrenia. A factor analytic study

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Structural brain abnormalities in the major psychoses: a quantitative review of the evidence from computerized imaging

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Schizophrenic syndromes, cognitive performance and neurological dysfunction.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

The relationship of negative schizophrenia to parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Dexamethasone suppression test in positive and negative schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

The effects of morning naps, car trips, and maternal separation on adrenocortical activity in human infants.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Childhood behavioral precursors of adult symptom dimensions in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Consistent sex differences in cortisol responses to psychological stress.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

The MCPP challenge test in schizophrenia: hormonal and behavioral responses

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Salivary Cortisol Levels throughout Childhood and Adolescence: Relation with Age, Pubertal Stage, and Weight

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Developmentally moderated expressions of the neuropathology underlying schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Prenatal developmental disturbances in the limbic allocortex in schizophrenics

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Intelligence in schizophrenia: meta-analysis of the research

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Developmental pathways to schizophrenia: behavioral subtypes.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Diurnal rhythm of plasma beta endorphin, cortisol and growth hormone in schizophrenics as compared to control subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Disturbed endocrine function in the psychoses. I: Disordered homeostasis or disease process?

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Antecedents of predominantly negative- and predominantly positive-symptom schizophrenia in a high-risk population

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Cortisol hypersecretion in depressed school-aged children and adolescents

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Sampling biases in studies of gender and schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Childhood roots of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Teacher reports as a predictor of a schizophrenia and borderline schizophrenia: a Bayesian decision analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021

Childhood emotional expressions, educational attainment, and age at onset of illness in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS0954579400007343

7 January 2021